LEXISCAN
- Product NDC
- 0469-6501
- 11-digit product format
- 004696501
- Labeler code
- 0469
- Product ID
- 0469-6501_8fb5b92b-3654-43ff-98d3-3ac23c9a0b10
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- regadenoson
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Astellas Pharma US, Inc.
- Application
- NDA022161
- Marketing category
- NDA
- Marketing start
- 2008-04-10
- Substance
- REGADENOSON
- Active strength
- .08 mg/mL
- Pharmacologic classes
- Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LEXISCAN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| REGADENOSON | .08 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2XLN4Y044H |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0469-6501-89 | LEXISCAN | 5 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 5 | | 13 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0469-6501 | LEXISCAN (REGADENOSON) INJECTION, SOLUTION [ASTELLAS PHARMA US, INC.] | 13 | Current NDC, Legacy NDC, 1 package rows | 20190129_057289f4-2e18-4c1e-bed4-6c1858e2ef16.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0469-6501-89 | 00469650189 | 5 mL in 1 SYRINGE, PLASTIC (0469-6501-89) | 5 ml | 2008-04-10 | 0000-00-00 | No | No | Current |